SB-0201

N/A

Report date: 2024/09/24 14:16:42

Base Information

Drug NameSB-0201
Drug Alias NameSB0201SB-0201
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSinfonia Biotherapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesSinfonia Biotherapeutics AB
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A